RHHBY
Biotech Sector Could Jump 25% on Roche-Genentech Deal
Read the full article: http://www.contrarianprofits.com/articles/biotech-sector-cou...
If the deal does go through it may be bad news for Roche and Genentech shareholders, according to Phase 1 Investor editor Rob Fannon in The Growth Stock Wire. But it would be good news for the biotech industry as a whole…
No ticker information available.
- Login or register to post comments
- Email this page